Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Shippers ‘losing faith’ in CBSA tech systems amid ongoing outages, glitches

May 1, 2026

Neither Norway nor Singapore: Decoding Canada’s new sovereign wealth fund

May 1, 2026

Bevacizumab Biosimilars Market Trastuzumab Biosimilars Market Analysis Report 2026: $2.42 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

May 1, 2026

B2BROKER Group Puts AI at the Core of B2TRADER as Technology Enters a New Era

May 1, 2026

Adalimumab, Infliximab and Etanercept Biosimilars Trastuzumab Biosimilars Research Report 2026: $8.05 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2035

May 1, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Aquant Mentioned in the 2024 Gartner® Emerging Tech: Demand Growth Insights for Generative AI Report
Press Release

Aquant Mentioned in the 2024 Gartner® Emerging Tech: Demand Growth Insights for Generative AI Report

By News RoomSeptember 16, 20243 Mins Read
Aquant Mentioned in the 2024 Gartner® Emerging Tech: Demand Growth Insights for Generative AI Report
Share
Facebook Twitter LinkedIn Pinterest Email

NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) — Aquant, a leader in AI-driven service intelligence, is proud to announce its mention in the 2024 Gartner Emerging Tech: Demand Growth Insights for Generative AI report1. The report identifies Aquant as a vendor in the GenAI Virtual Assistant space.

Gartner highlights that, “Demand for generative AI is currently driven by large enterprises, with communications, media and services leading industry interest.” According to this Gartner research, “As the market matures, Gartner expects small and domain-specific language models will mostly replace their larger counterparts.” Gartner also stated that “GenAI products and capabilities that are designed with the use case and user in mind will outcompete their generalized counterparts.”

“We are thrilled to be mentioned by Gartner as a vendor in this rapidly evolving and competitive space, where our focus on delivering domain-specific intelligence sets us apart and drives tangible value for the organizations we serve,” said Assaf Melochna, CEO and Co-founder of Aquant. “We think this mention underscores our commitment to developing AI solutions that are not only filling a critical gap in the service industry but also highly attuned and tailored to the specific needs of our customers.”

Aquant’s generative AI solutions empower service leaders by transforming data into actionable insights, enhancing troubleshooting capabilities, decision-making, and operational efficiency. By mining a company’s service history, documentation, and expert insights, Aquant’s AI-driven platform closes the Service Expertise Gap™—the shortage of talent needed to solve complex industry issues—by providing tailored recommendations based on user skills, problem complexity, machine condition, and customer needs. This equips teams with expert-level capabilities, enabling exceptional, personalized service that delights customers, reduces costs, and allows businesses to focus on revenue growth rather than customer escalations.

About Aquant

Aquant provides AI-powered tools that empower service teams in industries like manufacturing, medical devices, and industrial machinery to work smarter and more efficiently. The platform helps service leaders, field technicians, and contact center agents bridge the Service Expertise Gap™ by delivering expert-level recommendations tailored to each specific scenario. Aquant analyzes a company’s service data and expert insights, offering guidance that considers factors like skill level, problem complexity, and equipment state, ensuring precision and relevance. By continuously learning from real-world data and feedback, Aquant not only enhances troubleshooting but also enables proactive maintenance, effective training, and growth opportunities, turning service operations into a true business asset. Discover more at www.aquant.ai.

____________________
1 Gartner, Emerging Tech: Demand Growth Insights for Generative AI, Danielle Casey, 27 August 2024
GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved. Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

Contact
Micaela McPadden
[email protected]

An image accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b931cf34-9d5f-495c-b541-03319666805b

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Bevacizumab Biosimilars Market Trastuzumab Biosimilars Market Analysis Report 2026: $2.42 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

B2BROKER Group Puts AI at the Core of B2TRADER as Technology Enters a New Era

Adalimumab, Infliximab and Etanercept Biosimilars Trastuzumab Biosimilars Research Report 2026: $8.05 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2035

Whitespace Makes Iris, AI Intelligence Analysis Agent, Generally Available to Authorized DoW and IC Users

Based Eggman Announces Stage 3 Presale Progress

Systemic Mastocytosis (SM) Treatment Market 2026-2035: Industry to More Than Double in Size, Led by Sanofi, AdvaCare Pharma, and Cogent Biosciences

Investment Banking and Trading Services Market Analysis Report 2026: Bulge-Bracket Banks vs. Elite Boutiques

Shares, Opportunities and Strategies in the $1.7 Billion Ice Cream Maker Market, 2026-2035

Experts Highlight What Parents Need to Know About Child and Adolescent Mental Health

Editors Picks

Neither Norway nor Singapore: Decoding Canada’s new sovereign wealth fund

May 1, 2026

Bevacizumab Biosimilars Market Trastuzumab Biosimilars Market Analysis Report 2026: $2.42 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F

May 1, 2026

B2BROKER Group Puts AI at the Core of B2TRADER as Technology Enters a New Era

May 1, 2026

Adalimumab, Infliximab and Etanercept Biosimilars Trastuzumab Biosimilars Research Report 2026: $8.05 Bn Market Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2035

May 1, 2026

Latest News

Birdfy’s smart bird feeder is down to its best-ever price for Mother’s Day

May 1, 2026

Whitespace Makes Iris, AI Intelligence Analysis Agent, Generally Available to Authorized DoW and IC Users

May 1, 2026

Based Eggman Announces Stage 3 Presale Progress

May 1, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version